Form 4: Liquidity Services Inc. Executive Novelette Murray Sells Shares

Sentiment:

SEC Form 4 Filing


Novelette Murray, Chief Human Resources Officer of Liquidity Services Inc., sold 20,000 shares of common stock in two transactions on February 11 and 12, 2025.

Summary

  • Novelette Murray, the Chief Human Resources Officer of Liquidity Services Inc. (LQDT), reported changes in beneficial ownership.
  • On February 11, 2025, Murray sold 10,000 shares of common stock at a price of $34.44 per share.
  • On February 12, 2025, Murray sold another 10,000 shares of common stock at a price of $34.88 per share.
  • Following these transactions, Murray directly owns 44,119 shares of Liquidity Services Inc.
  • Murray also holds various restricted stock units and stock options with different vesting schedules and exercise prices.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing detailing stock sales by an executive, which is neutral in sentiment. It doesn't inherently indicate positive or negative performance for the company.

Industry Context

Form 4 filings are a routine part of regulatory compliance for publicly traded companies, providing transparency into the trading activities of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.

Comparison to Industry Standards

  • Executive stock sales are common and are often part of personal financial planning.
  • The impact of these sales on the stock price depends on the size of the sale relative to the trading volume and the overall market sentiment.
  • Comparable companies in the online auction and liquidation space also see regular Form 4 filings from their executives.

Stakeholder Impact

  • The stock sales could be perceived negatively by some shareholders if they interpret it as a lack of confidence in the company's future prospects, although this is a common practice.
  • Employees may be interested in the stock activity of key executives as it can reflect on the company's overall health.

Key Dates

DateDescription
01/01/2018Initial vesting date for some stock options.
01/01/2022Initial vesting date for some stock options.
01/01/2023Initial vesting date for some stock options and restricted stock units.
01/01/2024Initial vesting date for some stock options and restricted stock units.
01/01/2025Initial vesting date for some stock options and restricted stock units.
02/11/2025Sale of 10,000 shares of common stock at $34.44.
02/12/2025Sale of 10,000 shares of common stock at $34.88.
02/13/2025Date of Form 4 filing.
01/01/2026Vesting date for restricted stock units and stock options.
01/01/2027Vesting date for restricted stock units.
02/02/2027Exercisable date for some stock options.
01/01/2028Vesting date for restricted stock units.
01/01/2029Vesting date for restricted stock units.
12/01/2030Expiration date for some stock options.
12/07/2031Expiration date for some stock options.
12/23/2032Expiration date for some stock options.
12/22/2033Expiration date for some stock options.
10/30/2034Expiration date for some stock options.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.